Pharmafile Logo

antibiotic resistant bacteria

- PMLiVE

MHRA approves Advanz Pharma’s combined antibiotic to treat complicated infections

In England, approximately 130,000 patients are affected by bloodstream infections every year

- PMLiVE

Locus Biosciences announces first patient treated in urinary tract infection trial

Around 80% of UTI cases are caused by E coli, often including strains that are antibiotic resistant

- PMLiVE

The impact of COVID-19 on the fight against AMR

How the responses to the COVID-19 pandemic have affected antibiotic-resistant bacteria

- PMLiVE

New research shows drug candidate may effectively treat antibiotic-resistant bacteria

Research published in The American Chemical Society Central Science journal has shown that Fabimycin may be effective against more than 200 antibiotic-resistant bacteria

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links